Recruiting
Liquid Biospy for Urinary Cancers
NCT06116396
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Urology Department Milan, Italy
Clinical trial condition
Carcinoma, Transitional Cell
Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.
417 public trials
125 recruiting studies
Carcinoma, Transitional Cell trial results
NCT05600127
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Radboud UMC Nijmegen, Gelderland, Netherlands
- Jeroen Bosch ziekenhuis 's-Hertogenbosch, North Brabant, Netherlands
- Amphia ziekenhuis Breda, North Brabant, Netherlands
- Erasmus MC Rotterdam, South Holland, Netherlands
NCT06026189
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +20 more
- Locations
-
- SeARCH-trial Pijpers Rotterdam, Netherlands
NCT04617756
- Conditions
- Cancer, Carcinoma, Carcinoma, Transitional Cell, +4 more
- Locations
-
- Hôpital Bichat-Claude Bernard Paris, Paris Cx 20, France
- Institut Paoli Calmette Marseille, France
- Hôpital Saint Louis Paris, France
- Hôpital Pitié Salpétrière Paris, France
NCT05733000
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Enrolling by Invitation
Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
NCT07454941
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Diagnostic, +8 more
- Locations
-
- National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences Beijing Beijing, Chaoyang District, China
Enrolling by Invitation
Supporting Sexual Recovery in Women With Bladder Cancer
NCT07091565
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
- Locations
-
- King's College, London London, United Kingdom
Enrolling by Invitation
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
NCT07023848
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +16 more
- Locations
-
- Affiliated Hospital of Jiangnan University Wuxi, Jiangsu, China
Enrolling by Invitation
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
NCT07023861
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +16 more
- Locations
-
- Affiliated Hospital of Jiangnan University Wuxi, Jiangsu, China
Not Yet Recruiting
Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC
NCT07671092
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
- Locations
-
- Research Facility Christchurch, New Zealand